WASHINGTON -
Oct. 6, 2025 -
PRLog -- The
Global Medical Oxygen Concentrator Market is projected to grow from
USD 1.42 billion in 2025 to
USD 1.96 billion by 2030, reflecting a CAGR of 6.66%, according to a recent study by MarkNtel Advisors. This growth is driven by the increasing prevalence of chronic respiratory disorders, the rising geriatric population, and the rapid expansion of home healthcare and telemedicine services worldwide.
The market has witnessed strong adoption of portable oxygen concentrators, primarily due to their lightweight design, mobility, and ease of use, enabling patients to maintain independence while receiving oxygen therapy. These devices are increasingly preferred for patients suffering from COPD, asthma, pneumonia, and post-COVID respiratory complications, allowing them to manage their conditions effectively at home or on the move.
Technological advancements in oxygen concentrators are also fueling market growth. The latest models feature battery-powered systems, low-noise operation, energy-efficient mechanisms, and smart connectivity, including remote monitoring and mobile app integration. Such innovations enhance patient adherence, treatment efficiency, and clinical outcomes, while also opening opportunities for healthcare providers to offer telemedicine-
supported care. Leading companies, including Philips Respironics, Inogen, CAIRE INC., and O2 Concepts, are at the forefront of delivering these advanced solutions.
Get PDF Sample: https://www.marknteladvisors.com/query/request-sample/global-medical-oxygen-concentrator-market.html (This report contains affiliate links directing you to an external site to access the full research report.)
Market drivers include:
- Rising prevalence of chronic respiratory diseases: Increasing cases of COPD, asthma, and viral respiratory complications are creating continuous demand for reliable oxygen therapy solutions.
- Expansion of home healthcare and telemedicine services: Patients prefer in-home treatment to avoid hospital congestion, boosting demand for portable and user-friendly concentrators.
- Aging population in developed regions: Older patients require consistent oxygen therapy, further driving the market.
Regional insights show that
North America leads the market, accounting for approximately 33% of global revenue, due to advanced healthcare infrastructure, robust R&D, and high adoption of home care devices. Europe and Asia-Pacific are also witnessing growth, driven by improved healthcare access, government initiatives, and increasing patient awareness.
Challenges include the high cost of advanced devices, which may restrict access in developing countries. To overcome this, manufacturers are exploring cost-effective solutions, partnerships with healthcare providers, and insurance coverage to improve accessibility.
Recent developments highlight continued innovation:
- January 2025: CAIRE INC. launched IntenOxy 5 stationary oxygen concentrator for home use in the U.S.
With increasing respiratory health concerns, technological advancements, and a shift toward home-based care, the Global Medical Oxygen Concentrator Market is poised for significant growth through 2030, offering substantial opportunities for manufacturers, distributors, and healthcare providers to expand market share.
For detailed insights: https://www.marknteladvisors.com/research-library/global-medical-oxygen-concentrator-market.html
Account Phone Number